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Abstract
Background: Communication skills are known to decrease with advancing cognitive impairment. Analgesic
treatment in long-term care may be deficient due to the residents’ impaired ability to communicate their pain and
needs. Undertreated pain frequently leads to rising BPSD in residents with cognitive impairment, resulting in a
treatment with antipsychotics. Aim of this study was the analysis of differences in assessment and pharmacological
treatment of pain in nursing home residents relative to their cognitive state and ability to articulate pain.
Methods: Data stems from the baseline of a non-experimental pre-post-study in 12 Austrian nursing homes.
Residents’ pain prevalence in relation to pain assessment and cognitive decline was assessed, data on medical
diagnoses and prescriptions were retrieved from the nursing homes’ documentation (n = 425). Residents were first
divided into two groups: Residents with MMSE ≥ 18 were selected into group CUS (cognitively unimpaired/slightly
impaired), residents with MMSE ≤ 17 were selected into group CI (cognitively moderately to severely impaired).
CI residents were then sub-grouped according to their ability to communicate pain via the Verbal Rating Scale
(VRS) (i.e. group CI-V, group CI-NV). Pain behavior of CI residents was assessed with a modified German version of
PAINAD. Group differences were tested with ANOVA and H-test, 95 % confidence intervals were calculated and
associations were tested with log-binomial regression.
Results: Pain prevalence in CI residents irrespective of their ability to communicate pain was 80 % and exceeded
the CUS group prevalence significantly by 14 %. CI residents had significantly less analgesic prescriptions.
Furthermore, CI residents have a significantly higher risk of getting no analgesics when in pain than CUS residents
(CI-V: RR =2.6, CI-NV: RR =3.4). Use of antipsychotics was high in all groups (49 – 65 %) with more prescriptions in
the cognitively impaired group.
Conclusion: Results point toward an underuse of pain medication in cognitively impaired residents, especially
those unable to communicate pain verbally. The implementation of standardized pain assessments adapted to the
cognitive abilities of residents may foster the recognition of pain, warrant optimized pain management, reduce
inadequate medication and consequently raise the chance of equally effective pain treatment regardless of
cognitive state.
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Background
Pain is common in older people [1, 2], particularly in
nursing home (NH) residents [3, 4] and those with cog-
nitive impairment [5, 6]. Old age exposes individuals to
different types of pain, most commonly related to mus-
culoskeletal, gastrointestinal, neurological and cardiac
conditions, genitourinary infections, injuries, as well as
pressure ulcers in bed ridden individuals, with particu-
larly high pain prevalence rates in those suffering from
cognitive impairment [6, 7]. One recently published in-
vestigation based on health insurance claims data re-
ported no difference in the diagnoses indicating pain
between participants with incident cognitive impairment
and cognitively fit controls [8].
Since cognitive impairment is common in many
nursing home residents [9, 10], assessment and man-
agement of pain is particularly demanding for physi-
cians and nurses due to ambiguity in communication
leading to the reasonable assumption that pain in per-
sons with cognitive decline is both under-diagnosed
and under-treated [11–13]. In addition, use of analge-
sics has been reported with higher quality of life in
individuals with cognitive impairment [14]. There is
evidence that persons with advanced cognitive decline
either receive pain treatment, notably opioids, less
frequently or in lower insufficient doses as compared
to their cognitively fit counterparts [12, 15–19],
whereas only few studies have reported a possible
overuse of analgesics, particularly paracetamol, in pa-
tients with cognitive impairment [20]. On the other
hand, there is lack of information to which extent the
severity of cognitive decline affects the use of other
kind of medication, i.e. antipsychotics, since pain is
not only a frequent cause of behavioral and psycho-
logical symptoms in dementia (BPSD) [7, 21], but
may also, among others, stem from the under-
treatment of pain [7, 22]. Pain-induced disruptions
run the risk of being misinterpreted as BPSD, provok-
ing inappropriate prescription of psychotropic drugs
(i.e. antipsychotics) which, in turn, have been associ-
ated with compromised cognition, falls and fractures
and increased risk of death [23]. As mentioned above,
there is broad consensus within the literature that the
challenge of accurately identifying pain in cognitively
impaired individuals is the paramount cause of sub-
optimal management of pain [24]. Hence in 2009, the
American Geriatric Society recommended a compre-
hensive, disease-specific assessment to establish ad-
equate pain management on an individual level [25].
While individuals with mild to moderate cognitive
impairment are often able to report pain either ver-
bally or by use of rating scales [3, 26], these options
are not applicable for those with advanced cognitive
impairment when the ability to communicate is
severely impaired. Thus, self-reported pain may not
always be reliable in people with advanced cognitive
impairment and pain should be indirectly delineated
by raters using a validated observational instrument
[27]. Various numerical and visual scales are available
for self-reported experience of pain, all of them lack-
ing soundness in persons with cognitive impairment
due to their subjection on memory, abstract thinking
and speech comprehension [28].
Primary aim of our study was the comparison of
assessment and pharmacological treatment of pain in
Austrian NH residents in relation to their cognitive state
based on self-report and observational assessment of
prevalence and intensity of pain, generating the follow-
ing research questions:
– Are there any differences in the prevalence of pain
relating to cognitive state and mode of assessment?
Are there differences in diagnoses indicating pain
relating to cognitive state?
– Are there any differences in pharmacological pain
treatment relating to cognitive state? Are
cognitively impaired residents at higher risk of
experiencing pain without analgesic medication
than their cognitively better performing
counterparts?
Since BPSD may be a consequence of undertreated
pain, we additionally asked:
– Are cognitively impaired residents at a higher risk to
receive antipsychotics?
Methods
The presented cross-sectional data were collected as
part of a baseline investigation of a non-experimental
pre-post study with semi-standardized interventions
for optimizing pain management in nursing homes
(NH) in Austria (OSiA =Optimiertes Schmerzmanage-
ment in Altenpflegeheimen, German for: Optimized
pain management in nursing homes). Residents’ pain
prevalence in relation to pain assessment and cogni-
tive state was assessed and data on medical diagnoses
and prescriptions were retrieved from the nursing
homes’ documentation (n = 425). The study was ap-
proved by the ethical committee of Salzburg (415-E/
1412/4-2011 v. 07.10.2011). A written consent was
obtained from the nursing home residents or from
their legal representatives.
Institutions and study participants
The study was conducted in 12 facilities of one private
nursing home company in Austria, which were selected
from a total of 29 nursing homes by one-stage cluster
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sampling. Baseline data were collected in 2011/12. The
selected nursing homes are located in seven of the nine
Austrian federal states. Participants were recruited by
trained study-coordinators. For inclusion and exclusion
criteria see Table 1. Potential participants were anon-
ymized via code allocation.
Classification according to cognitive state
A validated German version of the Mini Mental Sta-
tus Examination (MMSE) [29] as suggested by Kaiser
et al. [30] was engaged to classify residents into
groups according to their cognitive abilities. Residents
with MMSE ≥ 18 were selected into group CUS (cog-
nitively unimpaired/slightly impaired), residents with
MMSE 17 and lower were selected into group CI
(cognitively moderately – severely impaired) [31]. CI
residents were then sub-grouped dependent on their
ability to communicate pain verbally via the Verbal
Rating Scale (VRS) [32, 33]: Residents who were able
to communicate pain verbally via the VRS were
termed group CI-V (verbally communicating), resi-
dents not able to communicate by VRS were termed
group CI-NV (not verbally communicating).
Measurement tools
Data collection was conducted by trained research as-
sistants with experience in geriatric care. Prevalence
and severity of pain of CUS were investigated by a
standardized questionnaire. Raters used tablets with
online versions of the questionnaire [computer
assisted personal interview (CAPI)]. The questionnaire in-
cluded a 5-item Verbal Rating Scale VRS (no – mild –
moderate – strong – unbearable pain) [32, 33].
Whenever possible, VRS was also used for CI resi-
dents. Pain was assessed at rest and during
mobilization (see PAINAD-Gm). Maximum pain was
defined as the residents’ maximum pain rating, both
at rest or during mobilization.
A modified German version of the Pain Assessment in
Advanced Dementia Scale (PAINAD-Gm) [34–36] was
engaged for observational assessment of pain behavior of
all CI residents. In accordance with [37], PAINAID-Gm
was assessed by means of standardized movements (lift-
ing arms, lifting legs, rolling over in bed or getting up
from a chair). A cut-off of two or more points out of ten
was used to identify residents probably experiencing
pain [38]. For group CI-V, maximum pain was recorded
as the residents’ maximum pain score either on the VRS
or the PAINAD-Gm.
Data on medical diagnoses, prescriptions and level of
care were recorded from the nursing homes’ documenta-
tion. Diagnoses were categorized according to organ
systems with diagnoses most likely associated with pain
(according to expert opinion) being labelled ‘Red Diag-
noses’ (Table 2).
Medicines prescribed to the residents were classified
on the basis of the Anatomical Therapeutic Chemical
(ATC) classification system recommended by the WHO
[39] additionally distinguishing between prescriptions
scheduled permanently (PP) and medications prescribed
‘as needed’ (PRN).
Since the risk of not receiving any analgesics was as-
sumed to be highest in residents who neither had PP anal-
gesics nor PRN analgesics prescribed, analyses regarding
the risk of having no analgesic medication though in pain
were based on a corresponding subsample.
Statistical analysis
Sample characteristics are presented as descriptive statis-
tics. Differences between cognition-groups were tested
with ANOVA for quantitative variables and with H-test
for dichotomous variables. Post-hoc analyses were con-
ducted via t-test and Dunn’s test. 95 % confidence inter-
vals and their fluctuation range for group differences were
calculated. Associations were tested with log-binomial re-
gression and calculated as risk ratios (RR). Type-1 error
(2-sided) was set to 5 % a priori.
Results
Characteristics of residents are summarized in Table 2.
The gender distribution was equal between the three
groups. CI-NV residents were significantly older than
the others. CI-V and CI-NV residents had a higher
classification in the level of care than CUS residents.
There were no differences in the length of stay in the
NH. CUS residents had a significantly higher number
of medical diagnoses than their CI-counterparts, but
fewer neurological diagnoses (i.e. dementia). Ortho-
pedic diagnoses were significantly higher in group
CUS than in group CI-V. Group CI-NV had signifi-
cantly less prescriptions scheduled permanently (PP)
than the other two groups.
Table 1 Inclusion and exclusion criteria
Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
- Age ≥ 60 - Short-term care (up to
6 weeks) and day care
- Living permanently (>3 months) in
the NH
- Congenital permanent mental
disabilities
- All levels of cognitive impairment - Insufficient German language
skills and/or aphasia
- All levels of physical impairment - Acute illness and life-
threatening situations
- Written consent from resident or his/
her legal representative
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Prevalence of pain, mode of assessment and diagnoses
indicating pain
66.4 % of CUS residents presented pain of different intensity
at rest or during mobilization. 68.1 % of CI-V residents
reported pain by the VRS, whereas the PAINAD-Gm indi-
cated pain in 69.0 %. Counting the maximum pain rating
from self-report or proxy assessment generates the best pos-
sible sensitivity when screening residents for pain, indicating
pain in 81.0 % of group CI-V. In the group CI-NV the pain
prevalence was 80.3 % (Fig. 1 and Table 3). Our results dem-
onstrate significant differences in pain prevalence between
CUS residents and both groups of CI residents (Table 3).
58.7 % of CUS residents, 43.5 % of CI-V and 48.5 % of
CI-NV residents exhibited at least one ‘Red Diagnosis’,
displaying a significant difference between CUS and
CI-V (Table 3).
Table 2 Characteristics of participants - descriptive statistics
Characteristics of participants
Groups All CUSb CI-Vc CI-NVd
Sample size (n (%)) 425 (100 %) 243 (57.2 %) 116 (27.3 %) 66 (15.5 %)
Sex female (n (%)) 315 (74.1 %) 172 (70.8 %) 88 (75.9 %) 55 (83.3 %)
Age (Mean ± SD) 83.6 ± 8.8 82.5 ± 9.4 84.4 ± 7.8 86.1 ± 7.5*
Level of care (Median of range 1–7) 5 4* 5 5
Length of stay in months (Mean ± SD) 29.7 ± 23.9 27.8 ± 20.8 31.2 ± 27.8 34.5 ± 26.3
Number of diseases (Mean ± SD) 7,4 ± 4.3 8,0 ± 4.7* 6.8 ± 4.0 6.5 ± 3.2
Disease categories (n (%))
Cardiology 305 (73.3 %) 179 (76.2 %) 83 (72.2 %) 43 (65.2 %)
Neurology 295 (70.9 %) 145 (61.7 %)* 91 (79.1 %) 59 (89.4 %)
Endocrinology 228 (54.8 %) 133 (56.6 %) 64 (55.7 %) 31 (47.0 %)
Orthopedics 204 (49.0 %) 128 (54.5 %)* 46 (40.0 %) 30 (45.5 %)
Subgroups of ‘Red Diagnoses’ (n(%)a)
Injuries and trauma sequelae 108 (49.1 %) 67 (48.6 %) 27 (54.0 %) 14 (43.8 %)
Arthrosis 74 (33.6 %) 50 (36.2 %) 13 (26.0 %) 11 (34.4 %)
Disorders of spine and extremities 67 (30.5 %) 49 (35.5 %) 11 (22.0 %) 7 (21.9 %)
Neuropathic 22 (10.0 %) 15 (10.9 %) 4 (8.0 %) 3 (9.4 %)
Number of prescriptions scheduled permanently (PP) (Mean ± SD) 9.0 ± 3.9 9.7 ± 3.9 8.8 ± 3.9 6.8 ± 3.2*
aPercentages are based on residents with at least one ‘Red Diagnosis’; significant test results are marked with * (p < 0.05)
b cognitively unimpaired/slightly impaired, c cognitively moderately to severely impaired, verbally communicating, d cognitively moderately to severely impaired,
not verbally communicating
Fig. 1 Pain prevalence related to resident group and measurement tool. Notes: VRS low to unbearable pain, PAINAID-Gm cut-off 2, sample CUS had 2
missing data; CUS residents were assessed with the VRS, in CI-V residents VRS and PAINAD-Gm were engaged, CI-NV residents were assessed by PAINAID-Gm
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Pharmacological pain treatment
Analgesics were the most commonly used medications in
the investigated nursing homes. CUS residents were more
likely to have analgesic prescriptions than the CI residents
(sum of analgesics PP and PRN). 87.0 % of group CUS got
at least one analgesic PP and/or PRN, while this applied to
78.3 % of group CI-V and 76.6 % of group CI-NV. In all
groups, more analgesics were prescribed PRN (64.1 –
72.3 %) than PP (36.0 – 58.0 %). In group CI-NV, fewer
analgesics were administered PP (36.0 %) than in group
CUS (58.0 %), whilst no such significant difference existed
between group CI-V and CI-NV (Table 4).
The most frequently prescribed analgesics (PP and/or
PRN) were weak cyclooxygenase (COX) inhibitors
(Metamizol, Paracetamol), found in 80.1 % of residents
with at least one analgesic prescription, where the differ-
ences between the cognition-groups were negligible.
Topical analgesics (e.g. diclofenac gel) were used by
40.5 % of all residents with analgesic medication and
39.9 % used opioids. Systemically administered NSAIDs
were prescribed in 36.7 % of all residents with at least
one analgesic prescription. Use of NSAIDs differed sig-
nificantly between all groups, with 44.4 % in group CUS,
28.9 % in group CI-V and 18.4 % in group CI-NV. Other
pharmacological painkillers were rarely used and due to
small number not further statistically analyzed (Table 5).
Focusing on PP analgesics, the most frequently pre-
scribed subgroups were opioids, found in 50.2 % of all
residents with PP analgesics, followed by topical
analgesics with 47.5 %, weak COX-inhibitors with 32.3 %
and NSAIDs with 26.7 %. There were no significant dif-
ferences between the cognition-groups.
Looking at the PRN analgesics, the most common
subgroup were weak COX-inhibitors prescribed for
82.6 % without differences between the cognition-
groups. Opioids as PRN were prescribed to 14.6 % of
group CI-NV, in contrast to 20.9 – 27.2 % for CUS
and CI-V, respectively. The only significant group dif-
ference in PRN analgesics was between group CUS
(35.5 %) and group CI-V (20.3 %) regarding NSAIDs
(Table 5).
The rate of residents without any analgesic medication
PP or PRN despite presenting pain differed between the
cognition-groups, increasing from 5.5 % in group CUS
to 13.9 % in group CI-V and 18.8 % in group CI-NV
(Fig. 2). The probability of having no analgesic prescrip-
tion despite indicated pain was significantly higher in
both groups of CI residents than in CUS residents and it
differed with regard to the ability to verbalize pain:
residents of group CI-V were at a 2.6-fold higher risk,
residents of group CI-NV at a 3.4-fold higher risk to be
affected (Table 6).
Antipsychotics
Notably, antipsychotics were commonly used in the
residents of the investigated NHs. 37.0 % of CUS residents
were prescribed at least one antipsychotic PP with 47.0
and 51.6 % as the corresponding numbers for groups
Table 3 Pain prevalence and ‘red diagnoses’ – descriptive statistics and group differences
Pain prevalence and ‘Red Diagnoses’
Descriptive statistics Group differences
Groups All CUSa CI-Vb CI-NVc CUS vs. CI-V CUS vs. CI-NV CI-V vs. CI-NV
% % % % Diff % (±FR) Diff % (±FR) Diff % (±FR)
Pain prevalence 72.6 66.4 81.0 80.3 14.6 (±9.2) ** 13.9 (±11.3) * −0.7 (±12.0) n.s.
At least 1 ‘Red Diagnosis’ 52.9 58.7 43.5 48.5 −15.2 (±9.2) ** −10.2 (±13.6) n.s. 5.0 (±5.0) n.s.
**p < 0.01, *p < 0.05, n.s. not significant, Diff Group difference, FR Fluctuation range of 95 % confidence interval
a cognitively unimpaired/slightly impaired, b cognitively moderately to severely impaired, verbally communicating, c cognitively moderately to severely impaired,
not verbally communicating
Table 4 Prescribed analgesics – descriptive statistics and group differences
Prescribed analgesics
Descriptive statistics Group differences
Groups All CUSa CI-Vb CI-NVc CUS vs. CI-V CUS vs. CI-NV CI-V vs. CI-NV
Diff % (±FR) Diff % (±FR) Diff % (±FR)
Sum of analgesics (PP and PRN)
(Mean ± SD)
2.11 ± 1.64 2.32 ± 1.63 1.90 ± 1.62 1.66 ± 1.61 0.4 (±0.35) * 0.7 (±0.45) ** 0.3 (±0.5) n.s.
At least one analgesic (PP and PRN) (%) 83.0 87.0 78.3 76.6 −8.7 (±8.7) * −10,4 (±11.2) * −1.7 (±12.8) n.s.
At least one analgesic (PP) (%) 52.0 58.0 48.7 36.0 9.3 (±11.0) n.s. 22.0 (±13.4) ** 12.7 (±15.0) n.s.
At least one analgesic (PRN) (%) 68.8 72.3 64.3 64.1 −8.0 (±10.4) n.s. −8.2 (±13.1) n.s. −0.2 % (14.7) n.s.
**p < 0.01, *p < 0.05, n.s. not significant, Diff Group difference, FR Fluctuation range of 95 % confidence interval
a cognitively unimpaired/slightly impaired, b cognitively moderately to severely impaired, verbally communicating, c cognitively moderately to severely impaired,
not verbally communicating
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CI-V and CI-NV, respectively. Although the probabil-
ity for CI residents to receive antipsychotics was
similar to that of CUS residents, the test results indi-
cate a trend (p < 0.1) toward more prescriptions for
CI-V residents and a significant increase (p < 0.05) in
risk of antipsychotic prescription for CI-NV residents
(Table 7).
Discussion
Our data confirm that pain is still a frequent symptom
in Austrian NH residents. More than two thirds either
self-report pain (VRS) or indicate prevalence of pain on
the PAINAID-Gm observational assessment. These find-
ings are in line with previously published data [37, 40].
In addition, reports of residents on their pain varied
depending on cognitive function and pain-assessment
instruments. Assessing moderately to severely cogni-
tively impaired individuals’ pain under standardized
conditions resulted in a high frequency of pain (approxi-
mately 80 %) compared to the literature [5, 6, 41]. Since
CI-V residents’ observational assessment showed signifi-
cantly higher pain prevalence than their self-report,
the true ratio of CI-V residents in pain is at issue.
Against this background and considering communica-
tion deficiencies in this group, the possibility of
higher pain prevalence than indicated through self-
report should be considered. By assuming the pres-
ence of pain, if at least one of both instruments
Table 5 Subgroups of analgesics - descriptive statistics
Subgroup of analgesicsa
all CUSb CI-Vc CI-NVd
weak cyclooxygenase (COX) inhibitors (Metamizol, Paracetamol) PP and PRN 80.1 % 79.7 % 78.9 % 83.7 %
PP 32.3 % 31.2 % 35.7 % 30.4 %
PRN 82.6 % 81.4 % 81.1 % 90.2 %
Topical analgesics PP and PRN 40.5 % 43.0 % 38.9 % 32.7 %
PP 47.5 % 49.3 % 48.2 % 34.8 %
PRN 15.7 % 15.7 % 23.2 % 22.0 %
Opioids PP and PRN 39.9 % 41.1 % 42.2 % 30.6 %
PP 50.2 % 50.0 % 50.0 % 52.2 %
PRN 21.6 % 20.9 % 27.2 % 14.6 %
NSAIDs PP and PRN 36.7 % 44.4 %* 28.9 %* 18.4 %*
PP 26.7 % 30.4 % 23.2 % 13.0 %
PRN 29.3 % 35.5 %* 20.3 %* 19.5 %
aPercentages are based on residents who had at least one prescription of each subgroup (PP and PRN, PP, PRN); significant test results are marked with *(p < 0.05)
b cognitively unimpaired/slightly impaired, c cognitively moderately to severely impaired, verbally communicating, d cognitively moderately to severely impaired,
not verbally communicating
Fig. 2 Residents presenting pain without any medical pain treatment in relation to cognitive groups. Notes: overall sample had 8 missing data
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indicates pain – as was done in this study – sensitiv-
ity is aimed for, however, specificity of pain detection
may be lowered.
In contrast to literature [12], our results demonstrate
differences in pain-associated diagnoses relating to
cognitive state with significantly more diagnoses indicat-
ing pain in the CUS group in comparison to the CI-V
group. This discrepancy cannot be interpreted from our
data, but may reflect a decreasing awareness in deter-
mining medical diagnoses for the cognition-groups with
advanced decline.
Our data adds to the evidence that persons with
advanced cognitive decline less often receive pain
treatment [12, 15–19] and, is therefore, conflicting with
reports from other European countries suggesting that an-
algesic use is higher among people with cognitive
impairment as compared to older adults without cognitive
impairment [8, 20, 42]. This may be explained by differ-
ences in national prescription habits and configuration of
medical supply. It has to be pointed out though that
frequency of analgesic prescription is not necessarily a
sign, whether (or not) an adequate analgesic treatment is
being prescribed to the right people at the right time [7].
It is noteworthy to add that we investigated the
percentages of permanently scheduled analgesics (PP) and
analgesics prescribed ‘as needed’ (PRN) in relation to the
different cognition-groups. In all groups, more analgesics
were prescribed PRN (64.1 – 72.3 %) than PP (35.9 –
58.0 %), with no significant group differences for the PRN
prescriptions. In contrast, PP prescriptions dropped
with cognitive decline, with 58.0 % for group CUS,
48.7 % for group CI-V and 36.0% for group CI-NV.
The difference between groups CUS and CI-NV
reached significance suggesting that advanced stages
of cognitive decline are associated with a reserved
attitude to medical treatment. This is also supported
by the mean numbers of prescriptions, which exhibit
a decline from group CUS (9.7 ± 3.9) to groups CI-V
(8.8 ± 3.9) and CI-NV (6.8 ± 3.2), again reaching sig-
nificance between CUS and CI-NV.
According to the literature, pain medication in individ-
uals with cognitive impairment is generally of low dos-
age and stronger drugs such as opioids are less likely to
be considered [7]. In our sample, the most frequently
prescribed PP pharmacological subgroups were opioids
with 50.2 %, followed by topical analgesics with 47.5 %,
weak cyclooxygenase inhibitors (Metamizol, Paraceta-
mol) with 32.3 % and NSAIDs with 26.7 %. No differ-
ences between the cognition-groups were detectable.
Notably, the number of opioid prescriptions is remark-
ably high in comparison to recent literature [15, 19], as
is the overall number of PP in our study. The high
number of opioid prescriptions is in accordance with
other investigations reporting an increasing opioid use
in several countries [43].
Merging PP and PRN prescriptions, the use of NSAIDs
diminishes significantly with the loss of cognitive func-
tion, showing a prevalence of 44.4 % in group CUS com-
pared to 28.9 and 18.4 % in groups CI-V and CI-NV,
respectively. This trend also partially applies to PRN
prescriptions. The lower NSAID prescription behavior
as cognition declines could, however, be also due to the
recommendation to prescribe this class of medication
less frequently due to its detrimental side-effects on
particularly the geriatric population [44–47].
Cognitively impaired individuals seem to experience
intensity and affective components of pain differently
than their cognitively fit counterparts [7]. Moreover, the
decline in the ability to communicate results in consid-
erable challenges for detecting pain, particularly in
advanced stages of cognitive impairment. Cognitively
impaired individuals may embody pain by BPSD, such as
agitation, denial or withdrawal, giving rise to mis-
interpreting pain as a psychiatric condition and resulting
in the inappropriate treatment with antipsychotic medi-
cation [7, 21].
In our sample, prescription of antipsychotics was strik-
ingly common, as reported previously for Austrian NH
residents by Richter (2012) [48]. The high number of
antipsychotic prescriptions is likely to be an indicator
for a perceived or actual lack of strategies to manage
BPSD [48]. Antipsychotics were prescribed in nearly half
of the participants of our study with the difference
between CI-V (47.0 %) and CUS (37.0 %) residents dem-
onstrating a trend and the difference between CI-NV
(51.6 %) and CUS (37.0 %) residents reaching statistical
Table 7 Antipsychotics PP - Associations between cognition
groups (Log-binomial regression)
Antipsychotics PP
Wald-Chi2 p-value RR (95 % CI)
CI-Vb in relation to CUSa 3.4 <0.1 1.3 (1.0 – 1.6)
CI-NVc in relation to CUSa 5.1 <0.05 1.4 (1.0 – 1.9)
RR Risk Ratio, CI Confidence Interval
a cognitively unimpaired/slightly impaired, b cognitively moderately to severely
impaired, verbally communicating, c cognitively moderately to severely
impaired, not verbally communicating
Table 6 No analgesics though in pain - Associations between
cognition groups (Log-binomial regression)
No analgesics despite pain
Wald-Chi2 p-value RR (95 % CI)
CI-Vb in relation to CUSa 6.9 <0.01 2.6 (1.3 – 5.1)
CI-NVc in relation to CUSa 10.8 <0.01 3.4 (1.6 – 7.2)
RR Risk Ratio, CI Confidence Interval
a cognitively unimpaired/slightly impaired, b cognitively moderately to severely
impaired, verbally communicating, c cognitively moderately to severely
impaired, not verbally communicating
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significance. In addition, residents with advanced cogni-
tive decline had a significantly higher risk of suffering
from pain without having an analgesic prescription,
giving rise to the assumption that pain-associated BPSD
indicate antipsychotic rather than analgesic treatment.
This finding adds to an ongoing discussion, since some
studies demonstrated that treatment of pain might de-
crease incidence and severity of BPSD [22, 49], whereas
a recently published meta-analysis does not support
strong associations between pain and BPSD [50].
To our best knowledge, our investigation is the first of
its kind to address the relationship between prevalence
of pain, prescription of analgesics and the application of
different assessment tools adjusted to the cognitive state
of NH residents. Connecting these aspects, CI-V resi-
dents had a 2.6-fold higher risk of suffering from pain
without having any analgesics prescribed as compared to
CUS residents; for CI-NV residents, this risk was even
3.4-fold. These findings suggest cognitive impairment as
a hindering factor for receiving sufficient medical pain
treatment. Against the background of communication
deficiencies, these considerable disparities may be traced
back to lacking or inadequate pain detection, which
further points toward the necessity of meticulous and
standardized pain assessment adapted to the residents’
cognitive state as a prerequisite of adequate treatment.
Moreover, such an assessment is mandatory to find the
balance between sufficient analgesia, side effects and
futile treatment, since patients are often restricted in
reporting the effect of therapy [40]. Along these lines,
recording the effect of pain treatment over time might
be a pivotal measure to warrant optimized pain manage-
ment and to avoid inadequate medications.
We concede some limitations to our work: Due to the
cross-sectional study design, it is difficult to make causal
conclusions about the data. Additionally, considering
nursing homes in Austria, it should be noted that re-
quirements related to staffing and facility structure are
regulated by federal law. Although our sample only
consisted of nursing homes from one Austrian nursing
home operator, which limits its generalizability, differ-
ences in staffing and facility structure between the
nursing homes in our sample and other nursing homes
are expected to be rather negligible. The quality of the
medical documentation in the nursing homes did not
allow the use of standardized tools to rate cumulative
illness, thus, limiting the comparability of disease burden
between the cognition- groups. Moreover, the medical
documentation only included information about pre-
scribed medication, but not if the prescribed medication
was actually given to or taken by the resident. The
classification of cognitive abilities was based on the
current assessment of the MMSE. Therefore, definitive
assignment to clinical entities or etiology is not
warranted. The use of antipsychotic drugs might be
biased by the presence of BPSD, which were not re-
corded systematically in the medical documentation of
the nursing homes. Due to different cognitive states of
the participants different pain assessment methods were
used.
Conclusions
Results point toward an underuse of pain medication in
nursing home residents with advanced cognitive decline,
especially those unable to communicate pain verbally.
The implementation of standardized pain assessments
adapted to the cognitive abilities of residents may foster
the recognition of pain, warrant optimized pain manage-
ment, reduce inadequate medication and consequently
raise the chance of equally effective pain treatment re-
gardless of cognitive state.
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